Philips Healthcare Innovation Center (HIC) introduces Intuis – A Made in India cath lab for India and growth markets
Pune, India – Royal Philips (NYSE: PHG, AEX: PHIA) today announced the introduction of Philips Intuis, its latest innovation in image-guided therapy. Intuis is an advanced, entry level catheterization lab (cath lab) designed, developed and manufactured at the Philips Healthcare Innovation Center (HIC) in Pune, India.
The introduction of Intuis marks an important milestone in HIC’s role as a healthcare innovation and manufacturing center for India and other growth markets. Intuis is one of the cornerstones of Philips strategy for extending access to affordable cardiac care in tier-II and tier-III cities in India. The clinically versatile cath lab announced today is already available in India and will be launched in other growth geographies as well.
The Made in India Philips Intuis, with its state-of-the-art live image guidance technology will open up new possibilities in interventional procedures in India and empower interventional cardiologists and vascular specialists to decide, guide and confirm the right therapy for their patients in real-time.
“We aim to deliver innovations to enhance existing image-guided minimally invasive therapies and to enable new ones,” said Bert van Meurs, General Manager Image Guided Therapy at Philips. “I am convinced that precision enabled by advanced live image guidance, coupled with affordability can make all the difference in cardiac care in India. Intuis with its image quality and economic value addresses the market need of affordable care. With today’s launch, we are reaffirming our commitment to locally relevant healthcare products that can provide a great experience to both patients and physicians.”
“Today interventional cardiologists need reliable systems that will help them perform a broad range of procedures,” said Rekha Ranganathan, General Manager Mobile Surgery, Philips Image Guided Therapy Systems and Head of Philips HIC. “This need is felt acutely in tier-II cities, where the availability of effective healthcare infrastructure is often a challenge. With Philips Intuis, we are addressing the evolving needs of cardiologists and patients beyond metro’s and tier-I cities.”
Philips Intuis has been developed by a multi-disciplinary team at HIC and follows Philips’ DoseWise X-ray dose management philosophy. A wide range of diagnostic and interventional procedures can be performed with the system, including cardiac, vascular and EP procedures, as well as ICD implants and non-vascular interventions. It enhances patient care by intelligent and intuitive integration of live imaging and real time therapy guidance.
Philips HIC in Pune offers full spectrum of capabilities ranging from innovation, design, R&D and services to manufacturing of healthcare products. HIC manufactures both interventional and diagnostic X-Ray systems. Since 2012, HIC has launched five global products: MobileDiagnost Opta, Allura FC, Allura Centron, BV Vectra and Primary Diagnost. The center has successfully installed over 1,000 systems in more than 80 different countries, including countries in Western Europe.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
Preview attachment Untitled Session37474 Edited .jpg
Untitled Session37474 Edited .jpg